POTTER MYRTLE S 4
4 · Guardant Health, Inc. · Filed Sep 17, 2025
Insider Transaction Report
Form 4
POTTER MYRTLE S
Director
Transactions
- Exercise/Conversion
Common Stock
2025-09-15+68→ 18,307 total - Sale
Common Stock
2025-09-17$55.63/sh−26$1,446→ 18,281 total - Exercise/Conversion
Restricted Stock Units
2025-09-15−68→ 69 totalExercise: $0.00→ Common Stock (68 underlying)
Footnotes (2)
- [F1]The restricted stock unit award vested as to 25% of the shares subject to such award on October 15, 2022. The remaining 75% of the shares subject to such award vests in substantially equal installments on each monthly anniversary of October 15, 2022 during the three-year period thereafter.
- [F2]Not applicable for Restricted Stock Units.